A groundbreaking advancement in cancer therapeutics has emerged from Washington University School of Medicine in St. Louis, where researchers have…
Read More
Fat-Engorged Immune Cells Identified as Key Drivers of Rapid Disease Progression in Multiple Sclerosis Patients
A collaborative research effort led by Daan van der Vliet and a multidisciplinary team from the Netherlands Institute for Neuroscience,…
Read More
Discovery of Foamy Microglia Linked to Rapid Multiple Sclerosis Progression and Failed Brain Repair Mechanisms
A collaborative research effort led by Daan van der Vliet and scientists from the Netherlands Institute for Neuroscience, Leiden University,…
Read More
EHA26: J&J’s multiple myeloma therapies impress with new data – Pharmaceutical Technology
The European Hematology Association (EHA) 2026 conference, held from June 11th to 14th in Stockholm, Sweden, served as a pivotal…
Read More
ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma – Pharmaceutical Technology
The rapidly evolving landscape of multiple myeloma treatment is witnessing a pivotal moment with the emergence of in vivo chimeric…
Read More
Why some brain cells are particularly vulnerable to multiple sclerosis
The enduring mission of Science News, established in the nascent years of the 20th century, continues to serve as a…
Read More
MEDVi Under Scrutiny Following FDA Warning, Deceptive AI Advertising, and Multiple Lawsuits
In 2024, OpenAI CEO Sam Altman famously predicted that a single entrepreneur, leveraging the transformative power of artificial intelligence, could…
Read More
Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
Piracicaba River Found to Contain Multiple Antibiotic Classes, Accumulating in Fish, Aquatic Plant Shows Mixed Remediation Potential
Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have identified multiple classes…
Read More
MEDVi’s Meteoric AI-Fueled Ascent Faces Scrutiny Amidst FDA Warnings, Allegations of Deceptive Marketing, and Multiple Lawsuits
A telehealth startup, MEDVi, recently lauded by The New York Times as a prime example of an AI-driven billion-dollar enterprise,…
Read More
